Demographics (3)
- Age - Subject age (phv00430417.v3.p3)
- SEX - Subject sex (phv00430413.v3.p3)
- SEX - Sex/gender of subject (phv00492631.v1.p3)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for IPF (phv00492632.v1.p3)
Imaging (1)
- BODY_SITE - Body site where sample was collected (phv00430419.v3.p3)
Race and Ethnicity (2)
- ETHNICITY - Subject ethnicity (phv00430414.v3.p3)
- NIH_RACE - Subject NIH race (phv00430415.v3.p3)
Substance Use (1)
- CIG_SMOKE - Ever/never smoking status (phv00430416.v3.p3)
Other (16)
- ANALYTE_TYPE - Analyte Type (phv00430420.v3.p3)
- CONSENT - Consent group as determined by DAC (phv00430406.v4.p3)
- Funding_Source - Project funding source (phv00430423.v3.p3)
- IS_TUMOR - Tumor status (phv00430421.v3.p3)
- SAMPLE_ID - Sample ID (phv00430418.v3.p3)
- SAMPLE_ID - Sample ID (phv00430411.v3.p3)
- SAMPLE_SOURCE - Cohort contributing the sample (phv00430427.v3.p3)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00430422.v3.p3)
- SOURCE_SUBJECT_ID - Subject ID from source study (phv00430409.v3.p3)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00430426.v3.p3)
- SUBJECT_ID - De-identified Subject ID (phv00430412.v3.p3)
- SUBJECT_ID - Subject ID (phv00430405.v3.p3)
- SUBJECT_ID - Subject ID (phv00430410.v3.p3)
- SUBJECT_SOURCE - Source study of subject if other (phv00430408.v3.p3)
- TOPMed_Phase - TOPMed Phase (phv00430424.v3.p3)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00430425.v3.p3)